BioSpace News Archive

Werewolf Therapeutics, Inc. today provided a business update and reported financial results for the second quarter ended June 30, 2022.

Aravive, Inc. today reported financial results for the second quarter ended June 30, 2022 and provided corporate updates.

Trevena, Inc. today reported its financial results for the second quarter ended June 30, 2022 and provided an overview of its recent operational highlights.

Bioventus Inc. today reported financial results for the three and six months ended July 2, 2022.

Altimmune, Inc. today announced financial results for the three and six months ended June 30, 2022, and provided a business update.

Taysha Gene Therapies, Inc. today reported financial results for the second quarter ended June 30, 2022, and provided a corporate update.

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced recent operational highlights and financial results for the second quarter ended June 30, 2022.

MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm” or the “Company”) a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it will release second quarter financial results for the three and six month period ended June 30, 2022 before markets open on Monday, August 15, 2022.

Synlogic, Inc. today announced a new drug candidate for the treatment of gout developed in partnership with Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming.

Elite Pharmaceuticals, Inc. announced today that the first quarter financial results of the 2023 fiscal year will be released on Monday, August 15, 2022.